Product correctly added to cart.

Axitinib

CAS 319460-85-0: Axitinib

Description:Axitinib is a small molecule tyrosine kinase inhibitor primarily used in the treatment of advanced renal cell carcinoma. It selectively inhibits vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, and VEGFR-3), which play a crucial role in tumor angiogenesis and growth. The chemical formula of Axitinib is C19H18N4O4, and it has a molecular weight of approximately 358.37 g/mol. This compound is characterized by its ability to interfere with the signaling pathways that promote blood vessel formation in tumors, thereby inhibiting tumor growth and metastasis. Axitinib is administered orally and is known for its relatively high bioavailability. Its pharmacokinetics include a moderate half-life, necessitating careful dosing to maintain therapeutic levels. Common side effects may include hypertension, fatigue, and gastrointestinal disturbances. Due to its mechanism of action, Axitinib is classified as an antineoplastic agent and is often used in combination with other therapies to enhance treatment efficacy in cancer patients.

Formula:C22H18N4OS

InChI:InChI=1S/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H,23,27)(H,25,26)/b12-9+

InChI key:InChIKey=RITAVMQDGBJQJZ-FMIVXFBMSA-N

SMILES:O=C(NC)C=1C=CC=CC1SC=2C=CC=3C(=NNC3C2)C=CC4=NC=CC=C4

  • Synonyms:
  • Ag 013736
  • Benzamide, N-methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-
  • Inlyta
  • N-Methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide
  • N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide
  • N-methyl-2-({3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl}sulfanyl)benzamide
  • Axitinib
Sort by


See more categories

This search does not contain any category.

Found 12 products.

discount label

Ref: 3B-A3479

50mg185.00 €
Estimated delivery in United States, on Tuesday 8 Apr 2025
discount label

(E)-N-Methyl-2-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide

CAS:319460-85-0

Ref: IN-DA0037NX

1g199.00 €
5g521.00 €
10mg25.00 €
50mg66.00 €
100mg72.00 €
250mg107.00 €
Estimated delivery in United States, on Tuesday 15 Apr 2025
discount label

Axitinib

CAS:319460-85-0

Ref: TM-T1452

1g207.00 €
25mg39.00 €
50mg49.00 €
100mg66.00 €
200mg85.00 €
500mg147.00 €
1mL*10mM (DMSO)52.00 €
Estimated delivery in United States, on Tuesday 15 Apr 2025
discount label

Axitinib

CAS:319460-85-0

Ref: 54-OR1027894

1g190.00 €
5g618.00 €
25g2,690.00 €
100mg61.00 €
250mg97.00 €
Estimated delivery in United States, on Wednesday 16 Apr 2025
discount label

Axitinib

CAS:319460-85-0

Ref: 7W-GP9798

5mg63.00 €
25mg185.00 €
Estimated delivery in United States, on Wednesday 16 Apr 2025
discount label

Axitinib

CAS:319460-85-0

Ref: 54-BUP17829

1g321.00 €
5g707.00 €
10g1,001.00 €
200mg125.00 €
500mg229.00 €
Estimated delivery in United States, on Wednesday 16 Apr 2025
discount label

Axitinib

CAS:319460-85-0

Ref: 4Z-A-188008

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Wednesday 16 Apr 2025
discount label

Axitinib

CAS:319460-85-0

Ref: AC-46380

1gTo inquire
250mgTo inquire
Estimated delivery in United States, on Monday 21 Apr 2025
discount label

Axitinib

Controlled Product
CAS:319460-85-0

Ref: 86-MM3922.00-0250

250mg1,169.00 €
Estimated delivery in United States, on Monday 21 Apr 2025
discount label

Axitinib

CAS:319460-85-0

Ref: 3D-FA18036

1g883.00 €
2g1,152.00 €
100mg223.00 €
250mg443.00 €
500mg651.00 €
Estimated delivery in United States, on Monday 28 Apr 2025
discount label

N-methyl-2-[[3-[(1E)-2-(pyridinyl) ethenyl]-[N-[(5hydroxy methyl furanyl)-hydroxymethyl]-1H-indazol-6-yl-thiol]]-benzamide

Controlled Product
CAS:319460-85-0

Ref: TR-M330435

5mg1,547.00 €
Estimated delivery in United States, on Tuesday 27 May 2025
discount label

Axitinib

Controlled Product
CAS:319460-85-0

Ref: TR-A794650

10mg309.00 €
50mg1,118.00 €
100mg1,773.00 €
Estimated delivery in United States, on Tuesday 27 May 2025
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".